Here's the live share price of Gennex Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Gennex Laboratories has gained 20.58% CAGR. Over the past year, the corresponding return has been -50.41%.
Gennex Laboratories’s current P/E of 17.42x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Gennex Laboratories | 9.96 | 1.78 | -0.63 | -16.79 | -52.76 | 21.61 | 20.58 |
Sun Pharmaceutical Industries | 1.08 | -1.32 | -2.30 | -5.58 | -13.67 | 22.86 | 25.44 |
Divi's Laboratories | 0.84 | -1.39 | -6.98 | 7.26 | 11.48 | 19.38 | 13.39 |
Cipla | -0.48 | -0.53 | 3.50 | 4.23 | -6.88 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -1.63 | -3.25 | 8.69 | 15.50 | 2.40 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 0.49 | 3.70 | -0.64 | 13.92 | -1.18 | 17.09 | 7.19 |
Mankind Pharma | -1.56 | 3.97 | 9.17 | 18.23 | 4.67 | 21.72 | 12.52 |
Zydus Lifesciences | -0.55 | 4.77 | 7.79 | 15.71 | -6.91 | 42.05 | 21.62 |
Lupin | 3.72 | 4.15 | 5.54 | 3.02 | -9.66 | 48.04 | 14.81 |
Abbott India | -0.88 | -4.93 | -2.46 | 2.81 | 7.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.56 | 3.02 | 14.49 | 14.40 | -11.41 | 20.01 | 14.29 |
Aurobindo Pharma | 3.96 | 0.18 | -1.58 | -1.88 | -29.64 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -2.57 | 5.17 | 25.57 | 45.12 | 21.20 | 77.31 | 32.95 |
Laurus Labs | -0.17 | 3.44 | 35.51 | 53.95 | 78.57 | 20.10 | 27.14 |
Biocon | -1.06 | -1.13 | 2.14 | 7.85 | -4.10 | 7.35 | -3.86 |
Anthem Biosciences | 1.87 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
GlaxoSmithKline Pharmaceuticals | -3.13 | -1.60 | -15.60 | 1.95 | -1.96 | 24.23 | 9.16 |
Cohance Lifesciences | -0.02 | 10.08 | -0.30 | -12.87 | -14.37 | 28.96 | 21.52 |
Gland Pharma | 6.20 | 2.52 | 15.71 | 30.13 | 9.43 | -4.11 | 2.12 |
Ipca Laboratories | -0.22 | -5.32 | -3.38 | -0.34 | -9.99 | 14.97 | 3.52 |
Over the last one year, Gennex Laboratories has declined 52.76% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (11.48%), Cipla (-6.88%). From a 5 year perspective, Gennex Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 11.36 | 11.53 |
10 | 11.52 | 11.55 |
20 | 11.82 | 11.75 |
50 | 12.56 | 12.23 |
100 | 12.8 | 12.8 |
200 | 13.96 | 13.79 |
In the latest quarter, Gennex Laboratories saw a rise in promoter holding to 23.62%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 76.38% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 08, 2025, 8:15 PM IST | Gennex Laboratories - Reg. 34 (1) Annual Report. |
Sep 04, 2025, 11:17 PM IST | Gennex Laboratories - Intimation Of Book Closure For AGM |
Sep 04, 2025, 10:58 PM IST | Gennex Laboratories - Board Meeting Outcome for For Meeting Held On 04Th September 2025 For Approval Of Board Reports And AGM |
Aug 26, 2025, 9:52 PM IST | Gennex Laboratories - Board Meeting Intimation for Fixing Date, Time And Venue Of 40Th AGM Of The Company |
Aug 14, 2025, 10:58 PM IST | Gennex Laboratories - Unaudited Financial Results For The Quarter Ended June 30, 2025 |
Gennex Laboratories Ltd. is a Public Limited Listed company incorporated on 29/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1990PLC011168 and registration number is 011168. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 94.58 Cr. and Equity Capital is Rs. 22.74 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gennex Laboratories is ₹12.59 as on Sep 16, 2025.
The Gennex Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Gennex Laboratories is ₹305.87 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Gennex Laboratories are ₹12.95 and ₹11.83.
The 52-week high/low is the highest and lowest price at which Gennex Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Gennex Laboratories is ₹29.00 and 52-week low of Gennex Laboratories is ₹10.84 as on Sep 16, 2025.
The Gennex Laboratories has shown returns of 6.42% over the past day, 1.78% for the past month, -2.63% over 3 months, -50.41% over 1 year, 21.61% across 3 years, and 20.58% over 5 years.
P/E ratio of and PB ratio of Gennex Laboratories are 17.42 and 1.68 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.